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Summary
The paradigm to explain antigen-dependent T cell re-
ceptor (TCR) signaling is based on the activation of
the CD4 or CD8 coreceptor-associated kinase Lck. It is
widely assumed that this paradigm is also applicable
tosignalingbybacterial superantigens.However, these
bacterial toxins can activate human T cells lacking Lck,
suggesting the existence of an additional pathway of
TCR signaling. Here we showed that this alternative
pathway operates in the absence of Lck-dependent
tyrosine-phosphorylation events and was initiated by
theTCR-dependentactivationof raft-enrichedheterotri-
meric Ga11 proteins. This event, in turn, activated
a phospholipase C-b and protein kinase C-mediated
cascade that turned on the mitogen-activated protein
kinases ERK-1 and ERK-2, triggered Ca2+ influx, and
translocated the transcription factors NF-AT and
NF-kB to the nucleus, ultimately inducing the produc-
tion of interleukin-2 in Lck-deficient T cells. The trigger-
ing of this alternative pathway by superantigens
suggests that these toxins use a G protein-coupled
receptor as a coreceptor on T cells.
Introduction
Activation of the Src family tyrosine kinase Lck is one of
the earliest events after engagement of the T cell recep-
tor (TCR). Once activated, this kinase phosphorylates
the immune receptor tyrosine-based activation motifs
(ITAMs) on the 3, d,g, and z subunits of the TCR complex,
providing the sites for recruitment and activation of
the syk family kinase ZAP-70. In turn, ZAP-70 phosphor-
ylates tyrosine residues in the cytoplasmic portion of
the transmembrane adaptor LAT that act as docking
sites for the assembly of a multimolecular signaling com-
plex. These ‘‘signalosomes’’ trigger several downstream
*Correspondence: madrenas@robarts.cacascades that ultimately determine the translocation and
activation of transcription factors leading to changes in
gene expression that characterize activated T cells
(Huang and Wange, 2004; Samelson, 2002). According
to this paradigm, Lck is required to activate mature
T cells with peptide-major histocompatibility complex
(MHC) molecule complexes (Palacios and Weiss, 2004).
A substantial amount of the Lck expressed by mature
T cells is associated with the CD4 or CD8 coreceptor
(Weil and Veillette, 1996; Zamoyska et al., 2003). In this
context, activation of Lck upon TCR binding to pep-
tide-MHC complexes occurs after engagement of the
CD4 or CD8 coreceptor molecules with MHC class II
molecules or MHC class I molecules, respectively, and
determines the pattern of early TCR signaling (Chau
et al., 1998; Li et al., 2004; Madrenas et al., 1997). The
molecular architecture that supports Lck-dependent T
cell activation under these conditions involves the for-
mation of dimers of TCR complexes, one engaged to
an agonist peptide-MHC complex and the other to an
endogenous peptide-MHC complex. The two engaged
TCRs are bridged by a coreceptor molecule that facili-
tates Lck transactivation and the initiation of TCR signal-
ing in response to conventional antigens (Krogsgaard
et al., 2005).
There is experimental evidence suggesting that the T
cell responses to bacterial superantigens (SAg) follow
a different paradigm from that applicable to conven-
tional antigens. For example, although most SAg are
recognized in the context of MHC class II molecules,
they are able to activate not only CD4+ T cells but also
CD8+ T cells (Fuller and Braciale, 1998; Herrmann and
MacDonald, 1993; Webb and Sprent, 1990), implying
that the conventional CD4 and CD8 coreceptor assign-
ment is not operational in these responses. Consistent
with this observation, human T cell responses to some
staphylococcal SAg such as enterotoxin B (SEB) or
C-1 (SEC1) have been reported to be resistant to CD4
blockade and do not require expression of the CD4 cor-
eceptor in the responding T cells (Bavari and Ulrich,
1995; Oyaizu et al., 1992). These observations suggest
that human T cell responses to bacterial SAg do not
require the CD4-associated Lck.
In addition to the cellular data, biochemical experi-
ments indicate that bacterial SAg such as Staphylococ-
cal enterotoxin E (SEE) can activate Lck-deficient,
CD42 or lo T cells (Criado and Madrenas, 2004; Rapecki
and Allen, 2002; Yamasaki et al., 1997). In fact, Lck is
not only dispensable but, as we and others have recently
shown, it can also downregulate SAg-induced T cell ac-
tivation by turning on a negative regulatory feedback on
TCR signaling (Criado and Madrenas, 2004; Methi et al.,
2005). Therefore, the ability of SAg to activate Lck-defi-
cient, CD42 T cells suggests that the binding of these
toxins to the TCR activates an additional pathway
distinct from the canonical Lck-dependent cascade.
The nature of this alternative pathway is unknown. By
using human primary T cells and T cell lines with well-
characterized genetic deficiencies (Abraham and Weiss,
2004), we show that the SEE SAg bypasses the need for
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68Lck and tyrosine phosphorylation of ZAP-70, LAT, and
phospholipase C (PLC)-g1 by activating the lipid raft-en-
riched, pertussis toxin-insensitive Ga11 proteins and its
downstream target phospholipase C-b (PLC-b). This
event triggers influx of Ca2+, activation of protein kinase
C (PKC) and of the mitogen-activated protein kinases
(MAPK) ERK-1 and ERK-2, translocation of NF-AT and
NF-kB transcription factors, and production of interleu-
kin-2 (IL-2). This alternative signaling pathway explains
why SEE and other bacterial SAg can overcome the
lack of CD4 and Lck to activate human T cells and pro-
vides a clue to understand the biological responses to
these bacterial toxins.
Results
The CD4 Coreceptor Is Dispensable for T Cell
Responses to Bacterial SAgs
Most bacterial SAgs are recognized in the context of
MHC class II molecules. However, they can activate
both CD4+ and CD8+ T cells, suggesting that the CD4
coreceptor is not operational in these responses (Fuller
and Braciale, 1998; Herrmann and MacDonald, 1993;
Kappler et al., 1989; Webb and Sprent, 1990). To docu-
ment the dispensability of CD4 in SAg-induced T cell re-
sponses, we determined the effect of CD4 blockade on
the response of human peripheral blood T cells by using
two different blocking antibodies against CD4 (OKT4
and RPA-T4). Human peripheral blood T cells re-
sponded to a set of staphylococcal and streptococcal
SAgs (SEA, SEB, SEC-1, SEE, TSST-1, SME-Z, SpeI,
SpeJ, SpeC) by producing substantial amounts of IL-2
(Figure 1A). More importantly, this response was not in-
hibited when blocking CD4 antibodies, either OKT4 or
RPA-T4, were added to the culture. The blocking activity
of these antibodies was confirmed in a mixed lympho-
cyte reaction (p < 0.05) (Figure 1B). Thus, bacterial
SAgs do not require the CD4 coreceptor to activate
T cells.
Lck Is Not Required for Activation of Peripheral
Blood T Cells by SAg
The lack of requirement of CD4 function to respond to
bacterial SAg suggests that Lck is not needed for this re-
sponse. This conclusion was corroborated by several
strategies. First, the response of primed human T cells
to SEE and antigen-presenting cells (APCs) was pre-
served under conditions of Lck inhibition with PP2,
a selective src kinase inhibitor (Figure 1C). In fact, as
we reported (Criado and Madrenas, 2004) and recently
confirmed (Methi et al., 2005), inhibition of Lck activity
with PP2 enhanced such a response by blocking a still
uncharacterized Lck-dependent negative feedback on
TCR signaling. Similar results were obtained for another
bacterial SAg from Streptococcus pyogenes (SME-Z)
(data not shown). Although others have previously sug-
gested that this response to SEE may be due to another
src kinase expressed in T cells such as Fyn (Yamasaki
et al., 1997), it is unlikely because PP2 inhibits Fyn and
Lck with similar IC50 (Hanke et al., 1996) and because
of the recent demonstration that Lck is needed for Fyn
activation (Filipp and Julius, 2004). The possibility that
the IL-2 response in the absence of Lck function was
due to contaminating peptidoglycan (PGN), a TLR2agonist present in gram-positive bacteria, was ruled
out by the finding that PGN did not reverse the lack of
IL-2 response to antibody-mediated TCR-CD3 ligation
under conditions of Lck inhibition (Figure 1D). In fact,
we observed that addition of PGN had an inhibitory ef-
fect on IL-2 response to OKT3, as previously reported
(Nakagawa and Murai, 2003).
Next, we confirmed the Lck independence of T cell re-
sponses to SAg by using different SAg as well as human
and mouse T cell lines and clones. The response to SEA
by a mouse TCR Vb3-expressing T cell clone and to SEE
and SME-Z of a human Vb8-expressing T cell line was
not affected by the lack of functional Lck (Figure 2A).
In contrast, Lck-deficient JCaM1.6 Jurkat T cells failed
to produce IL-2 in response to plate bound anti-TCR
and anti-CD28 (Figure 2B). We also tested the response
of Lck-deficient T cells to anti-TCR Vb (given the selec-
tive binding of SEE to TCR Vb), but we found that none
of the antibodies available were able to induce substan-
tial T cell activation.
To further support the dispensability of Lck in the re-
sponse to SEE-APCs stimulation, we performed Lck
RNA interference. Transfection of Jurkat T cells with
siRNA targeting Lck was able to knock down Lck protein
amounts by 35% (the maximum percentage achieved in
multiple attempts; p < 0.05). In these cells with decreased
Lck expression, we did not observe any decrease in the
amount of IL-2 produced upon stimulation with SEE-
APCs (Figure 2C).
Activation of Lck-deficient T cells by SEE was further
documented by upregulation of CD69 on the surface of
T cells (Figure 2D) and by the formation of immunologi-
cal synapses (Figure 2E). It is important to note that
the response to SEE by Lck-deficient T cells required
TCR-mediated recognition of the bacterial SAg because
the Jurkat JRT3 subline, which lacks TCR b expression
(Weiss and Stobo, 1984), did not respond to SEE
(Figure 2F), although it responded to PMA and ionomy-
cin (data not shown). To further demonstrate the TCR
dependence of the response to SEE of Lck-deficient T
cells, we generated ultrapure wild-type SEE as well as
a mutant form of this SAg in which the TCR-interacting
tyrosine residue at position 205 was mutated to an ala-
nine (Y205A). As control, we generated a SEE mutant
at a site distal to the TCR contact interface (K148A).
When the responses to these SAgs were tested, we
observed that the Y205A SEE failed to induce IL-2 pro-
duction by Lck-deficient T cells, whereas both the wild-
type SEE and the K148A SEE induced substantial IL-2
production by these cells (Figure 2G). Together, these re-
sults confirm with multiple approaches that the response
of human primary T cells and T cell lines to SEE and other
SAgs does not require the canonical Lck-dependent
signaling pathway (Criado and Madrenas, 2004; Rapecki
and Allen, 2002; Yamasaki et al., 1997).
Bacterial SAg Bypass the Lck Requirement by
Triggering an Alternative Signaling Pathway
The finding of T cell activation through the TCR in re-
sponse to a biologically relevant stimulus in the absence
of Lck provided an excellent opportunity to characterize
alternative TCR signaling pathways. Because one of the
earliest events upon TCR-induced Lck activation is the
recruitment and phosphorylation of ZAP-70 (Iwashima
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69Figure 1. CD4-Independent and Lck-Independent T Cell Activation by Bacterial SAgs
(A) PBMC (105 cells) were stimulated with 0.01 ng/ml of SEA, SEB, SEC-1, SEE, or TSST or 0.1 ng/ml of SEMZ, SpeI, SpeJ, or SpeC in the presence
or absence of 10 mg/ml of either OKT4 or RPA-T4 antibody. 48 hr later, supernatants were collected and IL-2 was measured by ELISA. Results
(mean 6 standard deviation of triplicates) are representative of three independent experiments.
(B) MLR of PBMC (105 cells) stimulated with the same number of syngeneic or allogeneic irradiated PBMC (5000 Rads) in the presence or
absence of 10 mg/ml of either OKT4 or RPA-T4 antibody. 4 day culture supernatants were collected and assessed for IL-2 by ELISA. The effect
of CD4 blockade on the allogeneic MLR was statistically significant (*p < 0.05). Results (mean 6 standard deviation of triplicates) are represen-
tative of two independent experiments.
(C) Human T cell blasts were prepared from peripheral blood lymphocytes as indicated in the Experimental Procedures and stimulated with
monocyte-derived dendritic cells and SEE in the presence or absence of increasing concentrations of the selective src kinase inhibitor PP2.
IL-2 production was measured by ELISA of overnight culture supernatants. Relative IL-2 production was calculated in relation to that of SEE-
stimulated T cells in the absence of PP2 (considered as 100%). *p < 0.05.
(D) Staphylococcal peptidoglycan (PGN) does not restore IL-2 production by human peripheral blood T cells lacking Lck activity. Human periph-
eral blood mononuclear cells (105 cells/well in triplicate for each group) were isolated from a normal volunteer and stimulated with OKT3 in the
absence or presence of the Lck-inhibitor PP2 (10 mM) and PGN (10 mg/ml). IL-2 production in 24 hr cultures was measured by ELISA. Results
(mean 6 standard deviation of triplicates) are representative of three independent experiments. *p < 0.05.et al., 1994), we examined the phosphorylation of ZAP-70
upon SEE-APCs stimulation in the Jurkat E6.1 T cell line
and its Lck-deficient derivative JCaM1.6. We found that
stimulation with SEE-APCs caused an increase in phos-
phorylation of ZAP-70 in E6.1 T cells but not in JCaM1.6 T
cells (Figure 3A). This result is in line with our previous
finding that ZAP-70-deficient T cells respond to SEE
(Shan et al., 2001). The absence of Lck activity in
JCaM1.6 T cells was confirmed by measuring Lck kinase
activity on the exogenous substrate enolase (Figure 3B).
The paradox raised by the IL-2 response to SEE in Lck-
deficient T cells in the absence of ZAP-70 phosphoryla-
tion (a reflection of its activation) could have been due
to low amounts of phosphorylation below detection
rather than true lack of phosphorylation of this kinase.
To rule out this possibility, we examined several other
steps downstream of ZAP-70 activation that would
have been amplified by ZAP-70 activation. We looked
at phosphorylation of one of the ZAP-70 substrates,
the linker for activated T cells (LAT), a key event for the
assembly of signalosomes connecting the TCR-proxi-
mal events to downstream signaling pathways (Chau
and Madrenas, 1999; Madrenas, 2003). Consistent with
the lack of ZAP-70 activation, we found that SEE-APCs
did not induce phosphorylation of LAT (Figure 3C). We
also examined tyrosine phosphorylation (activation) ofPLC-g1, a critical enzyme that directly binds phosphory-
lated LAT and mediates hydrolysis of inositol phospho-
lipids into diacylglycerol and inositol-(1, 4, 5)-trisphos-
phate (IP3) (Yablonski et al., 1998; Yablonski and
Weiss, 2001). Again, we failed to detect tyrosine phos-
phorylation of PLC-g1 in response to SEE by Lck-defi-
cient T cells (Figure 3D). Together, these findings estab-
lished that TCR signaling upon SEE recognition can take
place through a pathway other than the canonical Lck-
dependent pathway.
The Alternative Signaling Pathway Triggered
by SAg Leads to Activation of ERK and
PKC and to Ca2+ Influx
To characterize this alternative pathway, we first exam-
ined the effect of different kinase inhibitors on the re-
sponse of Lck-deficient T cells to SEE. We found that
the MEK inhibitor PD98059 inhibited the IL-2 response
to SEE by Lck-deficient T cells (Figure 4). In addition,
we observed that the PKC inhibitor G06850 markedly
inhibited the response of Lck-deficient T cells to SEE
(Figure 4). Similar results were obtained with other
PKC inhibitors (Ro¨-31-8220 and Rottlerin, data not
shown). In contrast, inhibition of PI3K by LY294002 did
not have any effect on the SEE-induced IL-2 production
by Lck-deficient T cells (Figure 4).
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70Figure 2. Lck Is Not Required for IL-2 Production by T Cells in Response to SEE
(A) Lck activity is not required for T cell responses to different superantigens. Untreated or PP2-treated (10 mM) mouse 3C6 T cells (expressing
TCR Vb3) were stimulated with the indicated concentrations of Staphylococcal Enterotoxin A (SEA), and APC and IL-2 production was measured
by ELISA after 24 hr of culture. Similar experiment was performed with Jurkat E6.1 T cells and Lck-deficient JCaM1.6 Jurkat T cells (both express-
ing TCR Vb8) with SEE or with the Streptococcal superantigen SME-Z and LG-2 APC. Results (mean 6 standard deviation of triplicates) are
representative of at least two independent experiments.
(B) Parental Jurkat T cells (E6.1) and their Lck-deficient counterparts (JCaM1.6) were stimulated with increasing concentrations of SEE and APC
(left) or plate bound anti-TCR plus anti-CD28 (5 mg/ml) (right). After 24 hr, culture supernatants were collected and assayed for IL-2 production by
ELISA. Results (mean 6 standard deviation of triplicates) are representative of four independent experiments. *p < 0.05.
(C) E6.1 Jurkat T cells were transfected either with Lck siRNA or with nucleotide control. 48 hr after transfection, T cells were collected and
activated with APCs and SEE (10 ng/ml). 24 hr supernatants were assessed for IL-2 production by ELISA. Intracellular Lck was determined
by flow cytometry with the DAKO IntraStaining kit (DAKO A/S, Glostrup, Denmark). Results (mean 6 standard deviation of triplicates) are
representative of three independent experiments. *p < 0.05.
(D) Jurkat E6.1 T cells and JCaM1.6 were stimulated with APC in the presence (thick line) or absence (thin line) of SEE (10 ng/ml) for 16 hr. Cells
were harvested, stained with FITC-labeled CD69 mAb, and analyzed by flow cytometer. Basal CD69 expression on Jurkat cells is shown by filled
profile.
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71Figure 3. Lack of Early Tyrosine Phosphorylation Signaling Events upon SEE Recognition by Lck-Deficient T Cells
(A) Tyrosine phosphorylation of ZAP-70 as shown by a phosphotyrosine immunoblot of ZAP-70 immunoprecipitates from E6.1 and JCaM1.6
Jurkat T cells (107/lane) activated by APC in the presence or absence of SEE (10 ng/ml) for 10 min; ZAP-70 immunoblotting confirmed equal load-
ing (bottom).
(B) Lck kinase assay of Lck immunoprecipitates from E6.1 and JCaM1.6 Jurkat T cells (107/sample) activated for 10 min with APC in the presence
or absence of SEE (10 ng/ml) or anti-TCR C305. Samples were incubated with enolase (160 mg/ml) in the presence of [g32P]ATP (10 mCi/sample),
resolved on 8% SDS PAGE, and analyzed with a PhosphorImager.
(C) Parental Jurkat T cells (E6.1) and their Lck-deficient counterparts (JCaM1.6) were stimulated with APC and SEE (10 ng/ml) for the indicated
times. Lysates were immunoprecipitated with LAT antisera and sequentially blotted for phosphotyrosine and for LAT (bottom).
(D) Lysates from E6.1 and JCaM1.6 Jurkat T cells stimulated for 10 min with APC and SEE at the indicated concentrations were used for immu-
noprecipitation of PLC-g1 and sequentially blotted for phosphotyrosine and for PLC-g1. Results in this figure are representative of at least three
different experiments.Consistent with the above functional results, we found
that Lck-deficient T cells responded to SEE with slightly
less but still substantial ERK-1 and ERK-2 activation
(Figure 5A), a remarkable finding when considering
that the current paradigm of TCR signaling makes
MAPK activation contingent on tyrosine phosphoryla-
tion of ZAP-70, of LAT, and of PLC-g1 (Finco et al.,
1998; Martelli et al., 2000; Williams et al., 1999). We
also looked at events that link ERK-1 and ERK-2 activa-
tion with IL-2 production in Lck-deficient T cells. Be-
cause IL-2 production requires Ca2+ influx, we examined
whether Lck-deficient T cells underwent Ca2+ fluxing in
response to SEE. We found that stimulation with SEE-
APCs induced marked intracellular Ca+2 mobilization in
Lck-deficient T cells. Such response was similar in mag-
nitude to that displayed by Lck-repleted T cells even
though JCaM1.6 T cells showed an 85% reduction in
Ca+2 mobilization when stimulated with ionomycin
(Figure 5B and inserts).
Next, we determined the activation state and translo-
cation of NF-AT and NF-kB, two transcription factors
involved in the upregulation of IL-2 gene transcription.
Nuclear and cytoplasmic fractions of resting and SEE-
stimulated E6.1 and JCaM1.6 T cells were prepared
and blotted for NF-AT. We found that stimulation with
SEE-APCs induced an increase of dephosphorylated(activated) NF-AT in the nucleus in Lck-repleted T cells
as well as in Lck-deficient T cells (Figure 5C). To assess
NF-kB activation, we determined the phosphorylation
of the cytosolic inhibitor of this transcription factor
(IkB), an event linked to activation of this transcription
factor. We found that activation of this transcription
factor occurred to a similar magnitude in Lck-deficient
T cells in response to SEE stimulation (Figure 5D). To-
gether, these data demonstrate that T cell activation
by SEE involves an additional pathway from the TCR
that is distinct from the canonical Lck-dependent path-
way and that can trigger by itself, in the absence of such
canonical pathway, the downstream responses required
for T cell activation, i.e., it can activate and translocate
transcription factors required for IL-2 gene expression.
SEE Triggers a Ga11 and PLC-b-Dependent Pathway
Because SEE triggered Ca2+ influx and PKC activation,
we hypothesized that a phospholipase C (PLC) other
than PLC-g1 had to be involved in such an alternative
pathway of TCR signaling because no PLC-g1 activation
was detected under these conditions. A candidate is
PLC-b, a PLC expressed by T lymphocytes (Miscia
et al., 1999). To assess the role of PLC-b, we utilized
the selective inhibitor of this enzyme U73122 and its
control compound U73343 and analyzed their effects(E) Jurkat E6.1 and JCaM1.6 cells were stimulated for 30 min with APC in the presence or absence of SEE (100 ng/ml), stained with anti-CD3-FITC
(green signal), and analyzed by confocal microscopy. White arrowheads point to putative immunological synapses at T cell-APC interface;
confocal figures are representative of at least 40–50 putative synapses for each group, as previously reported.
(F) Jurkat T cells E6.1 and their TCR b-deficient counterpart cells (JRT3) were stimulated with increasing concentrations of SEE and APC. After 24
hr, culture supernatants were collected and assayed for IL-2 production by ELISA. Results (mean6 standard deviation of triplicates) are repre-
sentative of three independent experiments.
(G) Lck-deficient JCaM1.6 Jurkat T cells were stimulated with APC and wild-type or mutant SEE molecules at the indicated concentrations as
above, and IL-2 production was measured by ELISA. Results (mean6 standard deviation of triplicates) are representative of three independent
experiments.
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Parental Jurkat T cells (E6.1) and their Lck-deficient counterparts (JCaM1.6) were stimulated with APC and increasing concentrations of SEE in
the presence of the indicated concentrations of the MEK inhibitor PD98059 (top), of the PKC inhibitor GO6850 (middle), and of the PI3K inhibitor
LY294002 (bottom) for 24 hr. Supernatants were then collected and assessed for IL-2 production by ELISA. Results for each point represent
mean6SEM. The decrease in IL-2 production observed for PD98059 and for LY294002 treatments were statistically significant (p < 0.05). Results
are representative of at least three different experiments.on ERK-1 and ERK-2 activation induced by SEE in Lck-
deficient T cells. We found that pharmacological inhibi-
tion of PLC-b resulted in an almost complete blockade
of ERK-1 and ERK-2 activation in Lck-deficient T cells
in response to SEE (Figure 6A). Such an effect was
also observed in Lck-repleted T cells although the mag-
nitude of this effect was not as intense (data not shown).
Next, we investigated the effect of PLC-b inhibition in
primary human T cells and found that SEE-induced T
cell responses were inhibited when the cells were treated
with the PLC-b inhibitor U73122. We observed that the re-
sponses to high-order CD3 crosslinking with OKT3 were
also inhibited byU73122,afinding thatcould beexplained
by residual activity of this compound on PLC-g1. To seg-
regate the effect of inhibitionof PLC-b from thatof PLC-g1
inhibition, we used the Lck inhibitor PP2. Lck is responsi-
ble for phosphorylation and activation of PLC-g1. We ob-
served that OKT3-induced ERK-1 and ERK-2 activationwas blocked, whereas SEE-induced activation of ERK-1
and ERK-2 was still detectable (Figure 6B), thus corrobo-
rating that phosphorylation of PLC-g1 is not required in
SEE-induced T cell response. To further confirm the in-
volvement of PLC-b in this response, we knocked down
PLC-b1 by RNA interference in the Lck-deficient
JCaM1.6 T cells. Under conditions of 60% to 75% down-
regulation of PLC-b, there was a significant decrease in
the amount of IL-2 produced in response to SEE-APCs
compared with the control (p < 0.05) (Figure 6C). Western
blots documented the selective decrease in PLC-b by
RNA interference whereas total ERK-1 and ERK-2 levels
were not affected (Figure 6C, right).
PLC-b is regulated by the pertussis toxin-insensitive
Gaq11 family of G proteins (Philip et al., 2002). These G
proteins have been previously linked to TCR signaling
after high degree of crosslinking of CD3 (Stanners et al.,
1995). Therefore, we hypothesized that these G proteins
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73Figure 5. SEE-Induced Activation of Lck-Deficient T Cells Triggers
ERK-1 and ERK-2 Activation, Ca2+ Influx, and Activation and Trans-
location of NF-AT and NF-kB
(A) Parental Jurkat T cells (E6.1) and their Lck-deficient counterparts
(JCaM1.6) were stimulated with APC and increasing concentrations
of SEE for 10 min. Whole-cell lysates were prepared and sequentially
immunoblotted for active ERK-1 and ERK-2 and total ERK-1 and
ERK-2 content.
(B) Jurkat E6.1 and JCaM1.6 T cells were loaded with fluo-3AM and
FuraRedAM. Baseline fluorescence ratio (fluo3/FuraRed) was mea-
sured for 2 min prior to the administration of SEE-loaded APC, and
reading of the fluorescence ratio was acquired for an additional 15
min. APC without SEE culture was used as a negative control (right
panel of inlets), and ionomycin (2 mg/ml) was used as a positive
control (left panel of inlets).
(C) Jurkat E6.1 and JCaM1.6 T cells were stimulated with SEE (10 ng/
ml) and APC for 10 min. Cytoplasmic fractions and enriched-nuclear
fractions were prepared for these samples as described in the
Experimental Procedures. NF-AT activation in these fractions was
evaluated by blotting for NF-AT and assessing dephosphorylated
NF-AT in the nucleus as indicated by appearance of lower NF-AT
band. Purity of the cytoplasmic and enriched nuclear fractions
was confirmed by immunoblotting for total ERK-1 and ERK-2 and
histone H2A, respectively.
(D) Jurkat E6.1 and JCaM1.6 T cells were stimulated with SEE
(10 ng/ml) and APC for the indicated times. Whole-cell lysatesare activated by SEE, and this would explain the activa-
tion of downstream events in Lck-deficient T cells. First,
we confirmed that Ga11 is expressed by Lck-deficient
Jurkat T cells. We fractionated JCaM1.6 T cells and
prepared soluble and lipid rafts fractions of these cells
because G proteins are enriched in these microdomains,
and we immunoblotted them for Ga11. JCaM1.6 T cells
expressed Ga11, and as reported for other G proteins
(Chini and Parenti, 2004), it localized within lipid rafts
(Figure 7A). The quality of the raft fractionation procedure
was confirmed by blotting for ERK-1 and ERK-2, which
partition in soluble fractions, and GM1, which partitions
in lipid rafts.
Next, we introduced a dominant-negative form for
Ga11 in Jurkat T cells with the idea that interference
with the function of this protein would inhibit the
response of T cells to SEE. We used the G208A Ga11
cDNA construct that has been extensively characterized
as a selective blocker of endogenous Ga11 proteins
(Stanners et al., 1995). We found that T cells stably trans-
fected with the Ga11 dominant-negative construct failed
to respond to SEE with activation of ERK-1 and ERK-2
(Figure 7B). In contrast, the same cells transfected with
a neomycin control gene responded normally. Similar
results were obtained upon transient cotransfection of
JCaM1.6 T cells (data not shown).
The involvement of Ga11 proteins in the T cell re-
sponse to bacterial SAg was further corroborated by
the observation that the early response of Lck-deficient
T cells to SEE was not inhibited by pertussis toxin
(Figure 7C), consistent with the fact that Gaq11 proteins
are insensitive to this toxin. Of interest, late responses
such as IL-2 production did show slight sensitivity to
pertussis toxin (Figure 7C), consistent with the multiple
coupling of G protein-coupled receptors with time (Her-
mans, 2003). We also knocked down Ga11 protein by
RNA interference in Lck-deficient T cells. Despite the
fact that the drop in Ga11 protein by this technique
was consistently small, we observed that T cells with de-
creased Ga11 expression had significantly lower IL-2
production in response to SEE than the control T cells
(p < 0.05) (Figure 7D). Western blots documented the se-
lective decrease in Ga11 by RNA interference, whereas
total ERK-1 and ERK-2 levels were not affected
(Figure 7D, right). Together, our results demonstrate
that SEE can bypass the requirement for Lck in TCR-de-
pendent activation via a Ga11-dependent pathway that
leads to PLC-b activation, influx of Ca2+, activation and
translocation of NF-AT and NF-kB, and IL-2 production.
Discussion
It is widely assumed that TCR signaling by bacterial SAg
follows the canonical Lck-dependent pathway used by
conventional peptide-MHC complexes and by anti-
body-mediated crosslinking of the TCR complex and
is characterized by the formation of signalosomes on
phosphorylated LAT. However, emerging evidence
were prepared and immunoblotted for phospho-IkB, which reflects
NF-kB activation. Total IkB immunoblotting confirmed equal loading
for each lane. Results in this figure are representative of at least
three independent experiments.
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(A) JCaM1.6 Jurkat T cells were incubated for 1 hr in the presence of the PLC-b inhibitor (U73122) (10 mM) or its inactive analog (U73343) prior to
stimulation with APC and SEE (10 ng/ml) for 10 min. Whole-cell lysates were prepared and sequentially immunoblotted for active ERK-1 and ERK-
2 and total ERK-1 and ERK-2 (to confirm equal loading).
(B) PBMC were incubated for 1 hr in the presence of the PLC-b inhibitor U73122 (10 mM) or the src kinase PP2 (20 mM) or the combination of both
prior to stimulation with SEE (10 ng/ml) for 10 min. Whole-cell lysates were prepared and sequentially immunoblotted for active ERK-1 and ERK-2
and total ERK-1 and ERK-2 (to confirm equal loading). Densitometric analysis of dually phosphorylated ERK-1 and ERK-2 is shown in the bottom
panel. Background signal level is shown by the dashed line.
(C) JCaM1.6 Jurkat T cells were transfected either with PLC-b1 siRNA or nucleotide control. 24 hr after transfection, cells were collected and
activated with SEE (1 ng/ml). 24 hr supernatants were assessed for IL-2 production by ELISA. PLC-b1 expression was determined in whole-
cell lysates by immunoblot, and equal loading was confirmed by ERK-1 and ERK-2 blotting. Results (mean 6 standard deviation of triplicates)
are representative of five independent experiments. *p < 0.05.indicates that bacterial SAg can also use an alternative
pathway. Such evidence includes the ability of these
bacterial toxins (but not of peptide-MHC ligands or
anti-CD3) to fully activate T cells lacking Lck, and also
T cells lacking ZAP-70 (Shan et al., 2001), and to do so
without any tyrosine phosphorylation events triggered
by a src kinase, ruling out a contribution of Fyn, the other
src kinase expressed in some mature T cells. The results
presented here demonstrate that the alternative TCR
signaling pathway triggered by SEE in the absence of
Lck involves the activation of Ga11 and its downstream
target PLC-b. The activity of PLC-b leads to Ca2+ influx
and to activation of PKC and ERK-1 and ERK-2. These
events then converge in the activation and translocation
of transcription factors required for de novo IL-2 gene
transcription and IL-2 production that defines full T cell
activation. Importantly, both the canonical and the alter-
native pathways crosstalk and can work in concert in
mature T cells, but activation of the Ga11-PLC-b path-
way is necessary and sufficient to activate T cells.
A role for G proteins, and in particular for those contain-
ing the Ga11 subunit, has been previously suggested for
TCR signaling and T cell activation (Coffield et al., 2004;
Ohmura et al., 1992; Stanners et al., 1995), and mice de-
ficient for the Ga11 regulator RGS2 have impaired T cellproliferation and IL-2 production (Oliveira-Dos-Santos
et al., 2000). In addition, Gaq-coupled receptors can
trigger NF-AT translocation (Boss et al., 1996) and NF-
kB activation (Liu and Wong, 2004), both key events for
the initiation of IL-2 gene transcription. However, the bio-
logical implications of these observations have remained
uncertain because they were generated in artificial sys-
tems (antibody-mediated crosslinking of the TCR-CD3
complex) or were masked by the presence of a fully oper-
ationalLck-dependent pathway. The evidence presented
here provides a biologically relevant condition in which
a G protein-dependent pathway emanating from the
TCR leads to full activation of mature T cells in the ab-
sence of confounding Lck-dependent events.
How SEE activates Ga11 remains to be determined.
One possibility is that TCR engagement by SEE induces
a high degree of TCR crosslinking as anti-CD3 do, and
this leads to G protein activation by aggregation of lipid
rafts where these proteins are enriched (Chini and
Parenti, 2004; Ohmura et al., 1992; Stanners et al., 1995).
Alternatively, bacterial SAg may concomitantly bind to
the TCR and to a Ga11 protein-coupled surface mole-
cule that then acts as a coreceptor and, through its
aggregation, facilitates the activation of Ga11. This pos-
sibility is consistent with the observation that binding of
Ga11-PLC-b-Mediated TCR Signaling by Superantigens
75Figure 7. SEE Activates Pertussis Toxin-
Insensitive Ga11 Proteins
(A) Ga11 is expressed by Lck-deficient
JCaM1.6 T cells. Lipid rafts (LR) and deter-
gent-soluble (S) fractions were isolated from
resting JCaM1.6 Jurkat T cells and immuno-
blotted for Ga11. Quality of the LR and S frac-
tions was assessed by immunoblotting for
GM1 and ERK-1 and ERK-2 as raft and cyto-
solic representative molecules, respectively.
(B) A Ga11 dominant-negative blocks the
T cell response to SEE. Whole-cell lysates
from stable E6.1 transfectants for Neomycin
control vector (Neo) or Ga11 dominant-nega-
tive mutant (G208A) were prepared and se-
quentially immunoblotted for active ERK-1
and ERK-2 and total ERK-1 and ERK-2.
(C) The G protein activated by SEE is pertus-
sis toxin insensitive. Lck-deficient JCaM1.6
Jurkat cells were incubated for 1 hr in the
presence of PTX (1 mg/ml) prior to stimulation
with APC and SEE (10 ng/ml). Whole-cell
lysates were prepared and sequentially im-
munoblotted for active ERK-1 and ERK-2
and for total ERK-1 and ERK-2. Lck-deficient
Jurkat cells (JCaM1.6) were incubated for 1 hr
in the presence of PTX at the indicated
concentrations prior to stimulation with APC and increasing concentrations of SEE for 24 hr. Supernatants were collected and assessed for
IL-2 production by ELISA. Results represent mean 6 SEM of three experiments.
(D) Effect of Ga11 RNA interference on SEE-induced T cell activation. JCaM1.6 Jurkat T cells were transfected either with Ga11 siRNA or nucle-
otide control. 24 hr after transfection, cells were collected and activated with APCs and SEE (0.01 ng/ml). 24 hr supernatants were assessed for
IL-2 production by ELISA. Ga11 expression was determined in whole-cell lysates by immunoblot and equal loading confirmed by ERK-1 and
ERK-2 blotting. Results for each point represent mean 6 SEM and are representative for three different experiments. *p < 0.05.the bacterial toxin to the TCR is still required for activa-
tion of this alternative pathway. As potential corecep-
tors, we thought of the chemokine receptors CXCR4
and CCR5, for which a costimulatory function during T
cell activation, through Ga11, has been recently claimed
(Molon et al., 2005). Of interest, these authors used an
experimental model based on SEE-induced activation
of Lck-repleted Jurkat T cells. However, chemokine re-
ceptors are not the putative coreceptors because sig-
naling through CXCR4 requires Lck and Lck-dependent
ZAP-70 phosphorylation (Inngjerdingen et al., 2002;
Kremer et al., 2003), because JCaM1.6 T cells do not ex-
press CCR5, and because antibody blockade of their
function did not prevent the response of Lck-deficient
T cells to SEE (C.B. and J.M., unpublished observa-
tions). We also ruled out the involvement of other con-
ventional G protein-coupled receptors for which primary
association with Gaq/11 and subsequent multiple G pro-
tein coupling have been reported (e.g., adrenergic re-
ceptors, muscarinic receptors), via pharmacological an-
tagonists (C.B. and J.M., unpublished observations). A
third type of SAg coreceptor candidate is lipid raft-en-
riched gangliosides because it has been previously re-
ported that SEB binds membrane glycosphingolipids
(Chatterjee and Jett, 1992) and because ligation of
GM1 can trigger some signaling events including ERK-
1 and ERK-2 activation (Duchemin et al., 2002; Janes
et al., 1999; Kiyokawa et al., 2005; Singleton et al.,
2000). Experiments are underway to explore the role of
gangliosides in the response to bacterial SAg.
Finally, our data help to explain the paradoxes regard-
ing human T cell responses to some SAg. The differenti-
ation of T cells along Th1 and Th2 pathways is, in part,
determined by the pattern of TCR signaling (Madrenas,2003). It has been proposed that Th1 differentiation is
relatively Lck independent while Th2 differentiation re-
quires Lck activity (al-Ramadi et al., 1996; Yamashita
et al., 1998). SEE-induced immune responses in vivo
have been mostly associated with a Th1 profile (Gehring
et al., 1998; Hamel et al., 1995), consistent with the dis-
pensability of Lck for immune responses to bacterial
SAg. Also, the CD4 independence of T cell responses
to some bacterial SAg (Herrmann and MacDonald,
1993; Webb and Sprent, 1990) and the ability to activate
CD8+ T cells despite these toxins being recognized in
the context of MHC class II binding (Bavari and Ulrich,
1995; Oyaizu et al., 1992) would be a reflection of the
ability of these toxins to bypass the requirement for
the conventional CD4 or CD8 coreceptor and its associ-
ated Lck kinase to initiate TCR signaling.
Experimental Procedures
Cells
Human peripheral blood mononuclear cells (PBMCs) were isolated
from healthy volunteers by Ficoll gradient centrifugation (Ficoll-
Paque Plus, Amersham Biosciences, Piscataway, NJ). T cell blasts
were generated from PBMCs by treatment with PMA (1 ng/ml) and
ionomycin (100 ng/ml) as previously described (Criado and Madre-
nas, 2004). Monocyte-derived dendritic cells (MD-DC) were gener-
ated from PBMCs by treatment with GM-CSF (1000 U/ml) and IL-4
(1000 U/ml) as previously described (Criado and Madrenas, 2004).
Human cells were obtained and processed in compliance with
research protocols approved by the Office of Research Ethics at
the University of Western Ontario. The Jurkat E6.1 T cell line and
the Lck-deficient Jurkat subline JCaM1.6 were purchased from the
American Tissue Culture Collection (Manassas, VA) and maintained
in RPMI + 10% FCS. The lymphoblastoid B cell line LG2 was pro-
vided by Dr. Eric Long (National Institutes of Health, Rockville, MD)
and maintained in RPMI + 10% FCS. Jurkat T cells were transfected
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76with a Ga11 wild-type cDNA (wt) or with a G208A Ga11 dominant-
negative cDNA (Jurkat Ga11 G208A) or with a control plasmid
(Neo Jurkat) as described (Stanners et al., 1995) and culture in
RPMI + 10% FCS as above except for the inclusion of 500 mg/ml
geneticin for selection. The mouse CD4+ Th1 clone 3C6 (which
expresses TCR Vb3) has been previously described (Madrenas
et al., 1995, 1997).
Antibodies and Reagents
The following monoclonal antibodies (mAb) were used in these
experiments: anti-CD3 UCHT-1, anti-CD4 RPA-T4, and anti-CD28
CD28.2 from eBioscience (San Diego, CA); anti-CD4 OKT4 from
Ortho Biotech Inc; anti-active ERK-1 and ERK-2 E10, anti-PLCg
B-6-4, IkB-3 polyclonal antibody, phospho-IkB-a (Ser32) polyclonal
antibody, and Histone H2A polyclonal antibody from Cell Signaling
Technology (Beverly, MA); anti-phosphotyrosine 4G10 was kindly
provided by Dr. B. Drukker (Oregon Health Sciences University,
Portland, OR). An ERK-1 and ERK-2 rabbit polyclonal antiserum
was purchased from StressGen (Victoria, BC, Canada). LAT rabbit
polyclonal antibody and ZAP70 rabbit polyclonal antiserum were
purchased from Upstate Biotechnology (Lake Placid, NY). FITC-
labeled anti-CD69, anti-NFAT-1 clone 1, anti-CXCR4 clone 12G5,
and anti-CCR5 clone 2D7 were obtained from BD Biosciences
(San Diego, CA). Goat anti-rabbit Ig HRPO conjugated was pur-
chased from BioRad (Hercules, CA). Sheep anti-mouse Ig HRPO
conjugated was obtained from Amersham Pharmacia Biotech Inc.
The anti-Ga11 mAb clone D-17 and the anti-PLC-b1 mAb clone
D-8 were purchased from Santa Cruz Biotechnology, Inc. The anti-
TCR IgM antibody C305 was kindly provided by Dr. A. Weiss (Univer-
sity of California at San Francisco) (Weiss and Stobo, 1984). The
selective Src-tyrosine kinase inhibitor PP2, the PKC inhibitor Bisin-
dolylmaleimide I (Go¨ 6850), the MAP kinase kinase (MEK) inhibitor
PD98059, and the phosphatidylinositol 3-kinase (PI3-kinase) inhibi-
tor LY294004 were all purchased from Calbiochem. The PLC-b inhib-
itor U-73122 and its inactive analog U-73343 were purchased from
Sigma-Aldrich (Oakville, ON). Pertussis toxin (PTX) was purchased
from List Laboratories (Campbell, CA). Staphylococcal enterotoxin
E was purchased from Toxin Technology (Sarasota, FL), and Staphy-
lococcal peptidoglycan was obtained from Sigma.
Generation of SEE Mutants
Wild-type SEE lacking the signal peptide was cloned by PCR from
S. aureus strain FRI913 into a modified version of the pET41a
expression plasmid (Novagen) where the enterokinase cleavage
site (DDDDK) is replaced with the tobacco etch virus (TEV) protease
cleavage site (ENLYFQG). The SEE Y205A and K148A mutants were
generated by megaprimer PCR. Proteins were expressed from
E. coli BL21(DE3) and purified by Ni2+-column chromatography
(McCormick and Schlievert, 2003), and the purification tags were
removed with auto-inactivation-resistant His7::TEV (Kapust et al.,
2001). The purified proteins ran as homogenous, single bands on
SDS-PAGE.
Cell Stimulation, Immunoprecipitation, and Western Blotting
Jurkat T cells were stimulated with LG2 cells as antigen-presenting
cells (APC) (5:1 ratio) preincubated with SEE for 40 min at 37ºC or
with anti-TCR antibody-coated plates. Plate bound anti-TCR wells
were prepared by incubation of C305 culture supernatants (1:10 di-
lution in PBS) at 4ºC followed by extensive washing with PBS. Cells
were subsequently lysed in 1% Triton X-100 lysis buffer, and the
lysates were directly analyzed by Western blot or after immunopre-
cipitation with antibodies on protein A/G agarose beads (Chau et al.,
1998; Slifka and Whitton, 2001). In the indicated experiments, Jurkat
cells or PBMC were preincubated with pertussis toxin or the PLCb
inhibitor U-73122 or its inactive analog U-73343 for 1 hr prior to
T cell activation.
Mixed Lymphocyte Reaction
PBMC (1 3 105) from a healthy donor were stimulated with irradi-
ated-PBMC (1 3 105) from a different donor in the presence or
absence of 10 mg/ml of anti-CD4 of OKT4 or RPA-T4. After 4 days,
supernatants were collected and assessed for IL-2 by ELISA.IL-2 Production
T cell blasts (5 3 104) were stimulated with MD-DC (1.6 3 103) and
SEE. Jurkat T cells (5 3 104) were stimulated with LG2 cells (2 3
104) and SEE in the presence or absence of the indicated protein in-
hibitors, with plate bound anti-TCR and soluble anti-CD28. For Per-
tussis toxin experiments, Jurkat cells were incubated with the toxin
for 1 hr before adding LG2 and SEE. Cell culture supernatants were
collected after 18–24 hr and assayed for IL-2 content by ELISA via
OptEIA human IL-2 Set (BD Biosciences). Data were analyzed with
MPM III 1.34 (BioRad) and GraphPad Prism software (GraphPad
Software Inc.).
Lck Kinase Assay
Jurkat T cells were stimulated with LG2 cells (5:1 ratio) preincubated
with SEE for 40 min at 37ºC for 10 min. Cells were subsequently lysed
in 1% Triton X-100 lysis buffer, and Lck was immunoprecipitated
with antibodies on protein A/G agarose beads (Chau et al., 1998;
Slifka and Whitton, 2001). Lck immunoprecipitates were washed
twice in the corresponding lysis buffer. Washed Lck immunoprecip-
itates were then incubated with 30 ml of kinase buffer containing
20 mM Tris (pH 7.6), 10 mM MnCl2, 1 mM ATP, 160 mg/ml rabbit mus-
cle enolase, and 5 mCi [g32P]ATP for 10 min at room temperature.
After incubation, 10 ml of 43 reduced sample buffer was added.
Lck immunoprecipitates were boiled for 5 min, centrifugated, and
resolved on 8% SDS-PAGE.
Intracellular Free Ca2+ Measurements
Jurkat T cells were loaded with the calcium indicator dyes fluo-3AM
(4 mg/ml) and Fura Red (10 mg/ml) (Molecular Probes, Inc., Eugene,
OR) in Hank’s balanced salt solution containing 4 mM Probenecid
(Sigma-Aldrich), 1% FBS, 1 mM calcium chloride, and 1 mM magne-
sium chloride for 30 min at 37ºC. Cells were analyzed in a FACS
Calibur cytometer (BD Biosciences). Baseline measurements were
collected for 2 min, ionomycin (2 mg/ml), SEE-pulsed LG2 cells, or
unpulsed LG2 cells were added, and measurement was continued
after pelleting Jurkat cells and LG2 cells, for an additional 15 min
period. Stimulus-induced changes in the intracellular Ca2+ concen-
tration were determined over time by monitoring the fluorescence
emission ratio fluo-3AM/Fura Red. Data were analyzed and plots
were generated with FlowJo software (Tree Star, Inc.).
Analysis of CD69 Upregulation by Flow Cytometry
Jurkat T cells were stimulated in 6-well plates with soluble anti-CD3
antibodies, with anti-CD3 coated beads, or with LG2 cells and SEE at
the indicated concentrations for 16 hr, harvested, and stained with
FITC-labeled anti-CD69. Cells were examined by flow cytometry
with a FACScalibur flow cytometer (Becton Dickinson, Mountain
View, CA).
Nuclear and Cytoplasmic Fractions Extraction
Jurkat T cells were stimulated with LG2 cells and SEE as described
above. Next, nuclear and cytoplamic fractions were prepared with
the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce
Biotechnology, Rockford, IL), according to manufacturer’s recom-
mendations. Nuclear and cytoplamic fractions were resolved by
SDS-PAGE and analyzed by Western blotting. Purity of the cytoplas-
mic and nuclear fractions was tested by immunoblotting for ERK-1
and ERK-2 and histone H2A, respectively.
RNA Interference for Ga11, PLC-b1, and Lck Gene Silencing
in JCaM1.6 Cells
The small interfering RNA (siRNA) against Ga11 was obtained from
Qiagen (Germantown, MD). The antisense sequence of the selected
oligos to target Ga11 gene were r(AUG GAC UCC AGA GUC AUC
G)dTdC and r(UUG AGG AAG AGG AUG ACG G)dAdG. siRNA
against PLC-b1 was purchased from Ambion (Austin, TX). The anti-
sense sequence of the selected oligos to target PLC-b1 gene were
AAGUCUAUUAACUUUUGGGtc, UUUUGAGAGGAAUACGCCCtt,
and AUGGGAGAUGUUCACGAGGtc. siRNA against Lck was per-
formed with the siGENOME SMARTpool reagent purchased from
Dharmacon (Lafayette, CO). Transfection was done with the Nucle-
ofector kit for cell lines from Amaxa biosystems (Gaithersberg,
MD) according to the manufacturer’s protocol. After 24 hr, siRNA
Ga11-PLC-b-Mediated TCR Signaling by Superantigens
77or control transfected cells were harvested and processed for cell
lysate preparation and IL-2 production.
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